Fideuram Asset Management Ireland dac Makes New $1 Million Investment in Marsh & McLennan Companies, Inc. $MRSH

Fideuram Asset Management Ireland dac purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,394 shares of the financial services provider’s stock, valued at approximately $1,001,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MRSH. Brighton Jones LLC increased its stake in Marsh & McLennan Companies by 51.2% during the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after acquiring an additional 2,960 shares during the last quarter. Bison Wealth LLC increased its stake in Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after acquiring an additional 869 shares during the last quarter. Glenview Trust co increased its stake in Marsh & McLennan Companies by 10.8% during the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock worth $852,000 after acquiring an additional 379 shares during the last quarter. Osterweis Capital Management Inc. increased its stake in Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after acquiring an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC acquired a new stake in shares of Marsh & McLennan Companies in the second quarter valued at about $1,307,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on MRSH. Cantor Fitzgerald increased their target price on Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Mizuho lowered their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Piper Sandler lowered their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Morgan Stanley lowered their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. Finally, JPMorgan Chase & Co. lowered their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research note on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Marsh & McLennan Companies currently has an average rating of “Hold” and an average target price of $203.56.

Get Our Latest Report on Marsh & McLennan Companies

Insider Buying and Selling

In related news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Trading Up 0.1%

Shares of MRSH opened at $159.73 on Friday. The company has a market capitalization of $77.17 billion, a P/E ratio of 19.97, a P/E/G ratio of 2.33 and a beta of 0.65. Marsh & McLennan Companies, Inc. has a one year low of $157.74 and a one year high of $235.78. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a 50-day moving average price of $164.87 and a 200 day moving average price of $172.02.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last issued its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. The firm had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.Marsh & McLennan Companies’s quarterly revenue was up 7.6% compared to the same quarter last year. Sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

See Also

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.